On the other hand, as bone remodeling is a lifelong process (Maggioli and Stagi, 2017), the inhibition of stage 2C (osteogenesis) might evoke adverse effects, such as fracture or osteoporosis, regardless of any HO suppression. This evidence concerns the gene HMOX1 and osteoporosis.